Last reviewed: June 21, 2026
Last updated: June 21, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works by mimicking glucagon-like peptide-1 (GLP-1), a hormone that regulates appetite and blood sugar. Many patients benefit from beginning treatment at lower doses to minimize adjustment-phase side effects while their body adapts to the medication. PlexusDx compounds semaglutide injections from licensed 503A pharmacies, allowing flexible titration schedules tailored to individual tolerance.
Understanding Semaglutide Microdosing and Starting Doses
Microdosing semaglutide means beginning treatment at the smallest effective dose, typically 0.25 mg weekly, then increasing in small increments over weeks or months. This approach allows your body to adjust to the medication's effects gradually, reducing nausea, fatigue, and gastrointestinal changes that some patients experience during rapid dose escalation. Unlike brand-name pens with fixed dose increments, PlexusDx compounded injections can be customized to your specific starting point and titration schedule.
Clinical data shows that patients starting at lower doses report higher treatment satisfaction and better adherence over time compared to those jumping to standard doses immediately. The gradual increase also helps identify the minimum dose that produces the appetite-suppressing and metabolic benefits you need, potentially reducing unnecessary medication exposure. PlexusDx providers work with you to establish a personalized starting dose based on your medical history, current medications, and tolerance expectations.
Step-by-Step Semaglutide Titration Protocol for Injection
A typical microdosing schedule begins with 0.25 mg injected subcutaneously once weekly for four weeks, allowing your body to establish tolerance to GLP-1 receptor activation. Week five through eight, the dose increases to 0.5 mg weekly, and patients often notice appetite reduction and improved satiety during this phase. By weeks nine through twelve, doses typically advance to 0.75 mg or 1.0 mg weekly, depending on your individual response and side effect tolerance.
Throughout this four-to-twelve-week titration window, keep a simple log of your appetite, energy levels, and any gastrointestinal symptoms to share with your PlexusDx provider. This documentation helps guide dose adjustments and ensures you're reaching therapeutic benefit safely. Maintenance doses for semaglutide injections typically range from 1.0 mg to 2.4 mg weekly, though PlexusDx providers may adjust based on your genetic predispositions and metabolic response markers.
Safe Injection Technique and Storage for Compounded Semaglutide
Proper injection technique reduces bruising, tissue damage, and medication waste. Choose a clean area of your abdomen, thigh, or upper arm, rotating injection sites weekly to prevent lipohypertrophy (thickened tissue buildup). Cleanse the skin with an alcohol swab, pinch a fold of skin, insert the needle at a 45- to 90-degree angle, and inject slowly over 3 to 5 seconds for even drug distribution.
PlexusDx compounded semaglutide arrives with detailed storage instructions: refrigerate at 36°F to 46°F until first use, then store at room temperature (68°F to 77°F) for up to 28 days once opened. Never freeze the medication, and keep it away from direct sunlight. If you travel, use an insulated cooling pouch with ice packs to maintain the cold chain, ensuring medication potency throughout your treatment cycle.
Managing Side Effects During Semaglutide Microdosing
Nausea and loss of appetite are common during the first two weeks of semaglutide treatment, but most patients report these symptoms improve by week three as the body adapts. Eating smaller, more frequent meals with adequate protein and staying hydrated can reduce nausea intensity. If nausea persists or worsens beyond week four, contact your PlexusDx provider—slower titration or temporary dose adjustment may help your body reach tolerance more comfortably.
Constipation is another frequent side effect caused by GLP-1's slowing of gastric emptying. Increase daily fiber intake gradually (not suddenly, which worsens bloating), drink 80 to 100 ounces of water daily, and consider a gentle stool softener if needed. Most adjustment-phase side effects resolve within four to six weeks as semaglutide levels stabilize in your system. PlexusDx providers monitor your progress via follow-up messages and adjust your dose schedule if side effects suggest a slower titration would benefit your treatment success.
Genetic Testing to Optimize Your Semaglutide Response
Not everyone responds identically to semaglutide because genetic variations in GLP-1 receptor structure, appetite-regulation pathways, and metabolic genes influence medication effectiveness and tolerability. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month of treatment), which analyzes 14 peptide-related pathways and 49 specific peptides to reveal your genetic predispositions for GLP-1 response. Key variants like GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313 predict how efficiently your body responds to semaglutide signaling.
With your genetic insights, PlexusDx providers personalize your titration speed, target maintenance dose, and medication choice (semaglutide, tirzepatide, or combination therapy) based on science, not guesswork. Patients with favorable GLP-1 receptor variants often tolerate faster titration schedules and require lower maintenance doses, while those with certain FTO or MC4R variants benefit from more conservative dose increases and adjunctive appetite-support strategies. This precision approach increases the likelihood of finding your optimal dose faster and maintaining long-term treatment success.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I start semaglutide at 0.25 mg, or do I have to begin at a higher dose?
You can absolutely start at 0.25 mg or even lower if medically appropriate. PlexusDx compounded semaglutide allows flexible starting doses based on your tolerance and provider recommendation, unlike fixed-increment brand pens. Your provider will help determine the safest entry point for your individual health profile.
How long does it take to see weight loss results with microdosed semaglutide?
Most patients notice appetite reduction within 1 to 2 weeks, but measurable weight loss typically becomes apparent by week 4 to 6 as the medication accumulates and your dose reaches therapeutic levels. Clinical trials show average weight loss of 5% to 15% over 12 weeks with semaglutide, with continued results over months as you titrate to maintenance doses. Individual results vary based on genetics, diet adherence, and exercise habits.
How much does compounded semaglutide cost, and does the price change as my dose increases?
PlexusDx compounded semaglutide injection starts at $149 per month and remains that flat price across all three commitment tiers—your dose may need to go up, but your price won't. No insurance is required, and the medication is HSA/FSA eligible, making personalized weight loss therapy accessible and transparent.
What are the most common side effects of semaglutide, and when do they stop?
Nausea, appetite loss, and constipation are most frequent during weeks 1 to 3, typically resolving by week 4 to 6 as your body adjusts. Less common side effects include fatigue, vomiting, and diarrhea. If side effects persist or worsen beyond week 6, notify your PlexusDx provider—dose adjustment or slower titration often resolves ongoing discomfort while maintaining treatment benefits.
Should I get the Precision Peptide Genetic Test, and what will it tell me about my semaglutide response?
The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first treatment month) analyzes your GLP-1 receptor genetics, appetite-control pathways, and metabolic variants to predict how well you'll respond to semaglutide and whether a faster or slower titration suits your biology. Patients with favorable GLP1R and GIPR variants often tolerate rapid dosing, while others benefit from conservative increases. This genetic roadmap increases your likelihood of success and helps your provider choose the most effective medication for your specific genetic profile.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Your Health Journey: Does Ozempic Show Up in Blood Work?
Recognizing Progress: How Do You Know When Ozempic Is Working?